CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Genprex, Inc. - GNPX CFD

0.8150
2.39%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0269
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.024068%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.001846%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.796
Open* 0.828
1-Year Change* -64.62%
Day's Range* 0.7949 - 0.8526
52 wk Range 0.74-2.67
Average Volume (10 days) 389.42K
Average Volume (3 months) 8.60M
Market Cap 41.01M
P/E Ratio -100.00K
Shares Outstanding 51.97M
Revenue N/A
EPS -0.47
Dividend (Yield %) N/A
Beta -0.37
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 22, 2023 0.7960 -0.0021 -0.26% 0.7981 0.8149 0.7775
Mar 21, 2023 0.7603 0.0151 2.03% 0.7452 0.7772 0.7283
Mar 20, 2023 0.7274 -0.0656 -8.27% 0.7930 0.7931 0.7210
Mar 17, 2023 0.7449 -0.0700 -8.59% 0.8149 0.8149 0.7283
Mar 16, 2023 0.7870 -0.0179 -2.22% 0.8049 0.8091 0.7558
Mar 15, 2023 0.7945 -0.0751 -8.64% 0.8696 0.8781 0.7677
Mar 14, 2023 0.8400 -0.1078 -11.37% 0.9478 0.9541 0.8400
Mar 13, 2023 0.8952 0.0272 3.13% 0.8680 0.9172 0.8505
Mar 10, 2023 0.8868 -0.1109 -11.12% 0.9977 1.0077 0.8779
Mar 9, 2023 0.9977 -0.0299 -2.91% 1.0276 1.0376 0.9937
Mar 8, 2023 1.0276 -0.0699 -6.37% 1.0975 1.0975 1.0077
Mar 7, 2023 1.0276 -0.0699 -6.37% 1.0975 1.1075 1.0176
Mar 6, 2023 1.0875 -0.0200 -1.81% 1.1075 1.1175 1.0875
Mar 3, 2023 1.1175 -0.0299 -2.61% 1.1474 1.1574 1.0875
Mar 2, 2023 1.1274 -0.0100 -0.88% 1.1374 1.1574 1.0576
Mar 1, 2023 1.1274 -0.1197 -9.60% 1.2471 1.2671 1.1174
Feb 28, 2023 1.2671 0.1597 14.42% 1.1074 1.3370 1.1074
Feb 27, 2023 1.1174 -0.1098 -8.95% 1.2272 1.2272 1.0975
Feb 24, 2023 1.3170 0.0000 0.00% 1.3170 1.3769 1.2970
Feb 23, 2023 1.3669 -0.3992 -22.60% 1.7661 1.8659 1.2871

Genprex, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 0 0 0 0 0
Revenue 0 0 0 0 0
Total Operating Expense 19.6008 17.9616 10.6827 12.3635 3.31235
Selling/General/Admin. Expenses, Total 10.9705 10.6359 8.7026 11.3862 3.01917
Research & Development 8.60775 7.30292 1.96701 0.97143 0.28993
Depreciation / Amortization 0.02253 0.02278 0.01307 0.00589 0.00324
Operating Income -19.6008 -17.9616 -10.6827 -12.3635 -3.31235
Net Income Before Taxes -19.5956 -17.9428 -10.6548 -12.3723 -3.31416
Net Income After Taxes -19.5956 -17.9428 -10.6548 -12.3723 -3.31416
Net Income Before Extra. Items -19.5956 -17.9428 -10.6548 -12.3723 -3.31416
Net Income -19.5956 -17.9428 -10.6548 -12.3723 -3.31416
Income Available to Common Excl. Extra. Items -19.5956 -17.9428 -10.6548 -12.3723 -3.31416
Income Available to Common Incl. Extra. Items -19.5956 -17.9428 -10.6548 -12.3723 -3.31416
Dilution Adjustment
Diluted Net Income -19.5956 -17.9428 -10.6548 -12.3723 -3.31416
Diluted Weighted Average Shares 47.0973 35.5229 16.027 13.771 13.035
Diluted EPS Excluding Extraordinary Items -0.41607 -0.5051 -0.6648 -0.89843 -0.25425
Dividends per Share - Common Stock Primary Issue 0
Diluted Normalized EPS -0.41607 -0.5051 -0.6648 -0.89843 -0.25425
Interest Income (Expense), Net Non-Operating 0.00513 0.01881 0.02791 -0.0088 -0.00181
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 0 0 0 0 0
Revenue 0 0 0 0 0
Total Operating Expense 5.72336 5.68292 3.43893 3.98722 6.4917
Selling/General/Admin. Expenses, Total 3.8558 2.19563 2.00044 2.4581 4.31631
Research & Development 1.86084 3.48033 1.432 1.52628 2.16914
Depreciation / Amortization 0.00673 0.00696 0.00649 0.00285 0.00624
Operating Income -5.72336 -5.68292 -3.43893 -3.98722 -6.4917
Interest Income (Expense), Net Non-Operating 0.00088 0.00099 0.00106 0.0011 0.00198
Net Income Before Taxes -5.72248 -5.68193 -3.43787 -3.98612 -6.48971
Net Income After Taxes -5.72248 -5.68193 -3.43787 -3.98612 -6.48971
Net Income Before Extra. Items -5.72248 -5.68193 -3.43787 -3.98612 -6.48971
Net Income -5.72248 -5.68193 -3.43787 -3.98612 -6.48971
Income Available to Common Excl. Extra. Items -5.72248 -5.68193 -3.43787 -3.98612 -6.48971
Income Available to Common Incl. Extra. Items -5.72248 -5.68193 -3.43787 -3.98612 -6.48971
Diluted Net Income -5.72248 -5.68193 -3.43787 -3.98612 -6.48971
Diluted Weighted Average Shares 47.8796 47.8353 47.6124 47.3725 45.5461
Diluted EPS Excluding Extraordinary Items -0.11952 -0.11878 -0.07221 -0.08414 -0.14249
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.11952 -0.11878 -0.07221 -0.08414 -0.14249
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 39.1402 27.7044 2.97664 8.84707 0.19357
Cash and Short Term Investments 38.6289 27.3197 2.00249 8.60092 0.16125
Cash 38.6289 27.3197 2.00249 8.60092 0.16125
Prepaid Expenses 0.51135 0.38455 0.17172 0.23685 0.02348
Total Assets 42.8623 31.3672 3.53423 9.26896 1.25954
Property/Plant/Equipment, Total - Net 0.04861 0.03944 0.04465 0.02435 0.0078
Intangibles, Net 3.66476 3.61267 0.4912 0.37945 0.29857
Other Long Term Assets, Total 0.00869 0.01074 0.02173 0.01809 0.75959
Total Current Liabilities 1.5853 0.45072 0.51068 0.38782 0.83096
Accounts Payable 0.9732 0.19297 0.43626 0.29507 0.62907
Notes Payable/Short Term Debt 0 0 0.07443 0.09275 0.20189
Total Liabilities 1.5853 0.45072 0.51068 0.38782 0.83096
Total Long Term Debt 0 0 0 0 0
Total Equity 41.277 30.9165 3.02355 8.88114 0.42857
Preferred Stock - Non Redeemable, Net
Common Stock 0.04787 0.04312 0.01926 0.01524 0.01172
Additional Paid-In Capital 119.247 89.2956 43.4837 38.6906 17.8692
Retained Earnings (Accumulated Deficit) -78.0179 -58.4222 -40.4795 -29.8247 -17.4524
Total Liabilities & Shareholders’ Equity 42.8623 31.3672 3.53423 9.26896 1.25954
Total Common Shares Outstanding 47.8747 43.1177 19.2638 15.2392 13.035
Total Receivables, Net 0 0.00013 0.00066 0.0093 0.00884
Accounts Receivable - Trade, Net 0 0.00013 0.00066 0.0093 0.00884
Total Inventory 0.80178
Other Current Liabilities, Total 0.6121 0.25776
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 35.7031 39.1402 45.6447 48.0615 50.3777
Cash and Short Term Investments 34.5553 38.6289 42.0205 44.2435 47.0687
Cash 34.5553 38.6289 42.0205 44.2435 47.0687
Total Receivables, Net 0.03217 0 0.00013 0.00013 0.00013
Accounts Receivable - Trade, Net 0.03217 0 0.00013 0.00013 0.00013
Total Inventory 2.87505 3.06236 3.1079
Prepaid Expenses 1.1156 0.51135 0.74903 0.7556 0.201
Total Assets 39.4094 42.8623 46.3272 48.7314 51.0365
Property/Plant/Equipment, Total - Net 0.04188 0.04861 0.04434 0.03949 0.0373
Intangibles, Net 3.65444 3.66476 0.62736 0.61967 0.6107
Other Long Term Assets, Total 0.01 0.00869 0.01074 0.01074 0.01074
Total Current Liabilities 2.38482 1.5853 1.16189 1.04722 0.61363
Accounts Payable 1.25298 0.9732 0.59194 0.36979 0.33897
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 1.13184 0.6121 0.56995 0.67743 0.27466
Total Liabilities 2.38482 1.5853 1.16189 1.04722 0.61363
Total Long Term Debt 0 0 0 0 0
Total Equity 37.0246 41.277 45.1653 47.6842 50.4229
Common Stock 0.04788 0.04787 0.0478 0.04752 0.04732
Additional Paid-In Capital 120.717 119.247 117.453 116.535 115.287
Retained Earnings (Accumulated Deficit) -83.7403 -78.0179 -72.3359 -68.8981 -64.9119
Total Liabilities & Shareholders’ Equity 39.4094 42.8623 46.3272 48.7314 51.0365
Total Common Shares Outstanding 47.8797 47.8747 47.8036 47.5229 47.3148
Other Equity, Total 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -19.5956 -17.9428 -10.6548 -12.3723 -3.31416
Cash From Operating Activities -14.2849 -13.9351 -6.91872 -6.84653 -2.17159
Cash From Operating Activities 0.02253 0.02278 0.01307 0.00589 0.00324
Non-Cash Items 4.27821 4.24619 3.52998 5.43538 1.32389
Changes in Working Capital 1.00995 -0.26128 0.19299 0.08454 -0.18457
Cash From Investing Activities -0.0838 -2.33725 -0.9469 -0.10332 -0.06342
Capital Expenditures -0.07244 -0.12799 -0.14512 -0.10332 -0.06342
Cash From Financing Activities 25.6779 41.5895 1.26719 15.3895 0.79397
Issuance (Retirement) of Stock, Net 25.6779 41.5895 1.26719 15.3895 0.79397
Net Change in Cash 11.3092 25.3172 -6.59843 8.43967 -1.44104
Other Investing Cash Flow Items, Total -0.01136 -2.20926 -0.80178
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -5.72248 -19.5956 -13.9137 -10.4758 -6.48971
Cash From Operating Activities -4.08386 -14.2849 -11.0668 -8.43209 -5.46528
Cash From Operating Activities 0.00673 0.02253 0.01558 0.00909 0.00624
Non-Cash Items 1.47011 4.27821 2.48457 1.8092 0.67174
Cash Taxes Paid 0 0
Cash Interest Paid 0 0
Changes in Working Capital 0.16179 1.00995 0.34669 0.22545 0.34645
Cash From Investing Activities 0.01032 -0.0838 0.08978 -0.07851 -0.11003
Capital Expenditures -0.00184 -0.07244 -0.04622 -0.02719 -0.10077
Other Investing Cash Flow Items, Total 0.01216 -0.01136 0.136 -0.05132 -0.00926
Cash From Financing Activities 0 25.6779 25.6779 25.4344 25.3243
Issuance (Retirement) of Stock, Net 0 25.6779 25.6779 25.4344 25.3243
Net Change in Cash -4.07354 11.3092 14.7008 16.9238 19.749
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.5144 1826600 1043 2022-12-31 LOW
Varner (John Rodney) Individual Investor 2.2348 1161535 625000 2023-02-18 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.069 555623 2408 2022-12-31 LOW
Confer (Ryan M.) Individual Investor 0.8379 435499 245000 2023-02-18 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8314 432137 -8520 2022-12-31 LOW
Berger (Mark Stanley) Individual Investor 0.4714 245000 245000 2023-02-18
Vaczy (Catherine M) Individual Investor 0.4714 245000 245000 2023-02-18
Kumar (Hermant) Individual Investor 0.3848 200000 200000 2023-02-18
UBS Financial Services, Inc. Investment Advisor 0.3089 160546 -119788 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2496 129739 0 2022-12-31 LOW
Cypress Capital, LLC Investment Advisor 0.1924 100000 0 2022-12-31 MED
Verus Capital Partners, LLC Investment Advisor 0.1703 88500 -2000 2022-12-31 MED
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1663 86430 11029 2022-12-31 LOW
Group One Trading, L.P. Research Firm 0.1161 60354 -79668 2022-12-31 HIGH
Silvercrest Asset Management Group LLC Investment Advisor/Hedge Fund 0.1077 56000 0 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.1056 54900 -18656 2022-12-31 HIGH
IHT Wealth Management, LLC Investment Advisor 0.1008 52375 0 2022-12-31 LOW
Staley Capital Advisers, Inc. Hedge Fund 0.0962 50000 0 2022-12-31 LOW
Citadel Advisors LLC Hedge Fund 0.0687 35688 21508 2022-12-31 HIGH
StoneX Group Inc. Research Firm 0.0676 35150 0 2022-12-31 HIGH

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group

500K+

Traders

92K+

Active clients monthly

$53M+

Monthly investing volume

$30M+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Genprex, Inc. Company profile

About Genprex Inc

Genprex, Inc. is a clinical-stage gene therapy company focused on developing treatments for cancer and diabetes. The Company's lead cancer drug candidate, REQORSA Immunogene therapy drug (also referred to as GPX-001), is being developed to treat non-small cell lung cancer (NSCLC). The active agent in REQORSA is a TUSC2 gene expressing plasmid that is encapsulated in a DOTAP cholesterol nanoparticle. TUSC2 is a tumor suppressor gene which has both tumor killing (via apoptosis) and immunomodulatory effects. The Company utilizes its ONCOPREX Nanoparticle Delivery System to deliver the TUSC2 gene expressing plasmid to cancer cells. Its diabetes gene therapy, also referred to as GPX-002, is designed to work by transforming alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body's immune system.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Genprex Inc revenues was not reported. Net loss increased 9% to $13.9M. Higher net loss reflects General and administrative increase of 13% to $8.8M (expense), Research and development increase of 3% to $5.1M (expense), Interest Income decrease of 76% to $4K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.39 to -$0.30.

Industry: Bio Therapeutic Drugs

Suite 3.322
1601 Trinity Street, Bldg. B
78712

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

69.49 Price
-0.590% 1D Chg, %
Long position overnight fee -0.0169%
Short position overnight fee -0.0050%
Overnight fee time 21:00 (UTC)
Spread 0.03

BTC/USD

28,344.65 Price
+3.050% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 60.00

Gold

1,991.37 Price
+1.080% 1D Chg, %
Long position overnight fee -0.0176%
Short position overnight fee 0.0094%
Overnight fee time 21:00 (UTC)
Spread 0.30

XRP/USD

0.45 Price
+4.850% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00422

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading